EDGE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Edge Therapeutics, Inc. - EDGE
NEW ORLEANS--(BUSINESS WIRE)--Dec 20, 2018--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Edge Therapeutics, Inc. (“EDGE”) (NasdaqGS: EDGE) with PDS Biotechnology Corporation in a stock-for-stock transaction. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( firstname.lastname@example.org ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-edge/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC 1100 Poydras St., Suite 3200 New Orleans, LA 70163
View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005561/en/
CONTACT: Lewis S. Kahn
KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Kahn Swick & Foti, LLC
Copyright Business Wire 2018.
PUB: 12/20/2018 11:00 AM/DISC: 12/20/2018 11:01 AM